+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Citeline - Market Research Reports

Citeline's analysis, insight and consultancy services span drug, device, company, clinical trial and market intelligence. All services are delivered by an authoritative team of industry experts in key markets around the globe.

Unilever Seeks End To Litigation Over St. Ives Scrub, Plaintiffs' 'Fake Medical Condition' - Product Thumbnail Image

Unilever Seeks End To Litigation Over St. Ives Scrub, Plaintiffs' 'Fake Medical Condition'

  • Newsletter
  • February 2026
  • 2 Pages
  • Global
From
Drug/Software Combo Platform Coming Soon To US FDA, Gottlieb Says - Product Thumbnail Image

Drug/Software Combo Platform Coming Soon To US FDA, Gottlieb Says

  • Newsletter
  • February 2026
  • 3 Pages
  • United States
From
The Advantages Of Providing Access To Unlicensed Medicines - Product Thumbnail Image

The Advantages Of Providing Access To Unlicensed Medicines

  • Newsletter
  • February 2026
  • 4 Pages
  • Global
From
Regulatory headaches: Brexit's not the only thing you need to worry about - Product Thumbnail Image

Regulatory headaches: Brexit's not the only thing you need to worry about

  • Newsletter
  • February 2026
  • 3 Pages
  • Global
From
Bone Grafts and Substitutes - Product Thumbnail Image

Bone Grafts and Substitutes

  • Newsletter
  • February 2026
  • 75 Pages
  • Global
Melanoma KOL Interview - US #2 - Product Thumbnail Image

Melanoma KOL Interview - US #2

  • Newsletter
  • February 2026
  • 12 Pages
  • United States
Acute Myeloid Leukemia (AML) KOL Interview - US, South - Product Thumbnail Image

Acute Myeloid Leukemia (AML) KOL Interview - US, South

  • Newsletter
  • February 2026
  • 16 Pages
  • United States
Pulmonary Hypertension KOL Interview - US #1 - Product Thumbnail Image

Pulmonary Hypertension KOL Interview - US #1

  • Newsletter
  • February 2026
  • 13 Pages
  • United States
Drug Delivery: Infusion Devices - Product Thumbnail Image

Drug Delivery: Infusion Devices

  • Newsletter
  • February 2026
  • 78 Pages
  • Global
2022 ASCO Weekend Update - Product Thumbnail Image

2022 ASCO Weekend Update

  • Newsletter
  • February 2026
  • 88 Pages
  • Global
Colorectal Cancer KOL Interview - US, Northeast - Product Thumbnail Image

Colorectal Cancer KOL Interview - US, Northeast

  • Newsletter
  • February 2026
  • 14 Pages
  • United States
Pulmonary Hypertension KOL Interview - US #2 - Product Thumbnail Image

Pulmonary Hypertension KOL Interview - US #2

  • Newsletter
  • February 2026
  • 11 Pages
  • United States
Interventional Neurology: Mechanical Thrombectomy Devices - Product Thumbnail Image

Interventional Neurology: Mechanical Thrombectomy Devices

  • Newsletter
  • February 2026
  • 76 Pages
  • Global
Molecular Diagnostics - Product Thumbnail Image

Molecular Diagnostics

  • Newsletter
  • February 2026
  • 100 Pages
  • Global
Kratom Industry Offers Own Standards As Another Firm Warned About FDA Rules - Product Thumbnail Image

Kratom Industry Offers Own Standards As Another Firm Warned About FDA Rules

  • Newsletter
  • February 2026
  • 3 Pages
  • Global
From
Real-World Evidence: US FDA's Prucalopride Review Shows Datasets' Utility And Limitations - Product Thumbnail Image

Real-World Evidence: US FDA's Prucalopride Review Shows Datasets' Utility And Limitations

  • Newsletter
  • February 2026
  • 4 Pages
  • United States
From
FDA Asks Whether Supplement Industry Has Outgrown Regulatory Framework - Product Thumbnail Image

FDA Asks Whether Supplement Industry Has Outgrown Regulatory Framework

  • Newsletter
  • February 2026
  • 3 Pages
  • Global
From
Roche's External Control Arms Show What Real-World Evidence Can Look Like In Practice - Product Thumbnail Image

Roche's External Control Arms Show What Real-World Evidence Can Look Like In Practice

  • Newsletter
  • February 2026
  • 4 Pages
  • Global
From
It's Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims - Product Thumbnail Image

It's Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims

  • Newsletter
  • February 2026
  • 3 Pages
  • Global
From
Vanda Warning Letter From US FDA Leaves Firm “Puzzled” - Product Thumbnail Image

Vanda Warning Letter From US FDA Leaves Firm “Puzzled”

  • Newsletter
  • February 2026
  • 3 Pages
  • United States
From
Loading Indicator